Comparison of Standard vs. Accelerated Corneal Crosslinking — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Comparison of Standard vs. Accelerated Corneal Crosslinking — Stella

Recruiting

Back to Keratoconus trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Price Vision Group, Indianapolis, Indiana

Key details

Phase

Safety & dosing / Large-scale testing

Sponsor

Price Vision Group

Enrollment target

~510 participants

Started

April 2019

Primary completion

June 2026

Age range

10 Years and older

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov